Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
低水平利福平单耐药结核病的治疗是否应该有所不同?
期刊:Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
影响因子:2
doi:10.1016/j.jctube.2021.100222
Gopie, F A; Commiesie, E; Baldi, S; Kamst, M; Kaur, D; de Lange, W C M; Pinas, P S; Stijnberg, D; Wongsokarijo, M; Zijlmans, C W R; de Zwaan, R; van Soolingen, D; Vreden, S G S; de Vries, G